
|Videos|July 12, 2020
Glaucoma 360: Accessible glaucoma care in 1 second (BELKIN Laser)
Author(s)Alex Delaney-Gesing
ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).
Advertisement
ICYMI: Daria Lemann Blumenthal, LLB, EMBA, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT), during the 2020 Glaucoma 360 meeting in San Francisco, California.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
4
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
5























